300685.SZ SHZ
Amoy Diagnostics Co., Ltd.
1W: +7.1%
1M: +23.1%
3M: +20.3%
YTD: +0.5%
1Y: -8.7%
3Y: -7.2%
5Y: -59.9%
¥21.34 ($3.18)
+0.34 (+1.62%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$342M
+14.4% ▲
5Y CAGR: +17.7%
Capital Expenditures
$40M
+10.4% ▲
5Y CAGR: +11.5%
Free Cash Flow
$302M
+18.8% ▲
5Y CAGR: +18.7%
Dividends Paid
$61M
-9.8% ▼
Buybacks
$86M
-615.2% ▼
Net Change in Cash
$114M
+369.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $180M | $239M | $264M | $261M | $255M |
| Depreciation & Amort. | $27M | $39M | $52M | $57M | $56M |
| Stock-Based Comp. | $47M | $15M | $2M | $0 | $0 |
| Change in Working Capital | -$11M | -$125M | -$59M | -$38M | -$14M |
| Other Non-Cash Items | $24M | $15M | -$109M | $18M | $45M |
| Operating Cash Flow | $221M | $168M | $149M | $299M | $342M |
| — Investing Activities — | |||||
| Capital Expenditures | -$58M | -$75M | -$78M | -$45M | -$40M |
| Acquisitions (Net) | $58M | $9M | $52M | $0 | $0 |
| Investment Purchases | -$1.3B | -$772M | -$364M | -$900M | -$628M |
| Investment Sales | $1.0B | $601M | $350M | $593M | $595M |
| Other Investing | -$58M | -$6M | -$484K | $19M | $216K |
| Investing Cash Flow | -$326M | -$243M | -$40M | -$332M | -$73M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$5M | $0 | $49M | $3M | -$7M |
| Stock Repurchased | -$3M | -$4M | -$101M | -$12M | -$86M |
| Dividends Paid | -$37M | -$55M | -$51M | -$55M | -$61M |
| Other Financing | $28M | $9M | -$118M | $46M | -$6M |
| Financing Cash Flow | -$18M | -$46M | -$121M | -$18M | -$160M |
| Net Change in Cash | -$137M | -$131M | $13M | -$43M | $114M |
| Cash End of Period | $362M | $231M | $244M | $201M | $315M |
| Free Cash Flow | $163M | $94M | $71M | $254M | $302M |